Dvorak Josef, Petera Jiri, Kabelac Karel, Melichar Bohuslav, Voboril Rene, Filip Stanislav, Vosmik Milan, Hulek Petr
Department of Oncology and Radiotherapy, Charles University Medical School & Teaching Hospital, Hradec Kralove, Czech Republic.
Hepatogastroenterology. 2006 Sep-Oct;53(71):702-4.
BACKGROUND/AIMS: The prognosis of inoperable carcinomas of esophagus is poor, and therapeutic efforts are generally limited to palliation. The aim of this study was to retrospectively evaluate the effectiveness of intraluminal high dose rate brachytherapy in the palliative treatment of tumorous esophageal stenoses.
Between February 1997 and July 2002 intraluminal brachytherapy was performed in 19 patients with inoperable esophageal carcinoma (squamous cell carcinoma in 14 cases and adenocarcinoma in 5 cases). All patients had dysphagia at presentation. Brachytherapy was performed using high dose rate afterloading system.
Dysphagia was improved in all patients. The mean survival was 248 days. No mechanical complications were observed during introduction of the applicator.
Our experience indicates that intraluminal brachytherapy is an effective and safe method of palliation of dysphagia caused by malignant esophageal stenosis.
